Your search for ‘Smart & Biggar’ returned 2,497 results

The reports include information on the number of submissions or applications made and the number of approvals in Q1 of 2020-2021.

On August 22, 2018, the Minister of Health tabled the 2017 Annual Report with the Clerks of the House of Commons and the Senate.

In life sciences, licensing fees are often upfront payments, ongoing royalties or milestone payments after a certain event in product development.

The United States Patent and Trademark Office (USPTO) has launched a new initiative called the "Patents 4 Partnerships" IP Marketplace Platform.

The Attorney General of Québec, who represents the Office québécois de la langue française ("OQLF"), has filed a Notice of Appeal from the decision of the Québec Superior Court issued on April 9, 2014 by which the Court confirmed that businesses can continue using their registered trade-marks on public signs outside their premises in the Province of Québec without the need to add French generic language.

On the eve of a section 8 trial, the Ontario Superior Court granted Abbott and Takeda leave to amend their pleadings to assert that Apotex's purported non-infringing alternative (NIA)

CIPO has adopted a practice whereby, upon entry of a PCT application into the Canadian national phase, CIPO will obtain the sequence listing directly from WIPO, if it was filed as part of the international application in electronic form.

Rather, the Court's role is to determine whether the plaintiff raises an arguable case such that it is not plain and obvious the action will fail.

This is a new consolidated publication that will communicate updates to CADTH's drug review process.

After an unpredictable few weeks, Bill C-45, the Cannabis Act, received Royal Assent on June 21, 2018, and adult use cannabis will be legal in Canada as of October 17, 2018.

For complete details about these pharmaceutical proceedings, click here.

This morning, the PMPRB released the final Guidelines operationalizing the amended Patented Medicines Regulations (Amended Regulations).

In a news release on June 7, the Government announced that it was suspending the implementation of the "private right of action" provisions in Canada's anti-spam legislation (CASL)...

A pair of recent decisions under the Canadian Internet Registration Authority ("CIRA") Domain Name Dispute Resolution Policy ("CDRP") demonstrate that a trademark owner who fails to obtain a domain name transfer at a first panel hearing may nonetheless achieve a favourable outcome upon a second panel hearing.

On November 22, 2024, the pan-Canadian Pharmaceutical Alliance (pCPA) released its 2023-2024 impact report.

The Canadian Agency for Drugs and Technologies in Health (CADTH) has released a consultation document for a Proposed Process for Time-limited Reimbursement Recommendations.

CADTH is now known as Canada's Drug Agency (CDA-AMC or CDA). Its mandate extends beyond CADTH's mandate to include...

After filing a new drug submission for its ustekinumab biosimilar PYZCHIVA (Janssen's STELARA), Samsung commenced the underlying action against...